Researchers are exploring the use of synthetic gene circuits to regulate next-generation cell-based therapeutics. These circuits may have applications in areas such as tumor immunotherapy and cancer immune responses, potentially leading to safer and more effective treatments. The development of these synthetic gene circuits involves various approaches, including design principles, computational identification of small molecules, and multidimensional control of therapeutic human cell function.